Hepatic Pharmacokinetic Profile for Vaniprevir (MK-7009) and Hepatitis C Virus RNA Levels After Vaniprevir Administration (Study MK-7009-029-02)
| Status: | Archived |
|---|---|
| Conditions: | Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2010 |
| End Date: | July 2011 |
A Multiple Dose Study to Evaluate Pharmacokinetics and Hepatitis C Virus RNA Following Administration of MK-7009 in Hepatitis C Infected Patients
This study will evaluate the hepatic (liver) and plasma pharmacokinetics of Vaniprevir
(MK-7009) by evaluation of RNA of the hepatitis C virus (HCV) in genotype 1, HCV-infected
participants.
We found this trial at
1
site
Click here to add this to my saved trials
